It is thought that RANKL increases while OPG is decreased, leading to an increase in the ratio of RANKL to OPG, enhancing osteoclastogenesis in common bone diseases, such as osteoporosis and RA [80]. This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.